首页 > 最新文献

BMC Clinical Pathology最新文献

英文 中文
Primary breast angiosarcoma: a rare presentation of rare tumor - case report. 原发性乳腺血管肉瘤:罕见肿瘤的罕见表现- 1例报告。
Q2 Medicine Pub Date : 2017-08-29 eCollection Date: 2017-01-01 DOI: 10.1186/s12907-017-0055-y
Fayçal Abbad, Najat Cherif Idrissi, Btissam Fatih, Bouchra Fakhir, Jamal Drissi, Mouna Khouchani, Hanane Rais

Background: Primary breast angiosarcoma is defined as malignant proliferation showing endothelial differentiation. It is a very rare tumour (0.05% of primary mammary cancers), whose diagnosis can be difficult.

Case presentation: We report the observation of a patient with no previous history, aged 27 years. The clinical examination finds a right breast discreetly increased in volume. The trucut biopsy was in favour of a lactating tubular adenoma. However, an immunohistochemical complement was requested. An absence of pancytokeratin labelling contrasted with strong expression of CD31, CD34 (endothelial markers) are described. The proliferation index (Ki67) was estimated at 30%. This led to the conclusion that the phenotypic aspect is related to a vascular proliferation that evokes an angiosarcoma. After a multidisciplinary assessment, the patient benefited from an enlarged excision of the tumour. The histopathological examination of the surgical specimen found an infiltrating mesenchymal proliferation made of vessels of variable sizes anastomosed to vascular slits with lesional limits. The immunohistochemical examination on the surgical specimen showed to the same phenotypic profile on biopsy. The final diagnosis was a high-grade mammary angiosarcoma of incomplete excision. The patient refused any additional surgical management; external radiotherapy and close supervision were prescribed. After eight months of evolution, no local or remote recurrence was reported.

Conclusion: Primary breast angiosarcoma is a mesenchymal malignant tumour of rare vascular origin. Our observation is peculiar by the absence of any prior radiotherapy, its clinical presentation, its morpho-phenotypic characteristics, its management and its evolutive aspects.

背景:原发性乳腺血管肉瘤被定义为具有内皮分化的恶性增生。这是一种非常罕见的肿瘤(占原发性乳腺癌的0.05%),其诊断可能很困难。病例介绍:我们报告一位无既往病史的患者,年龄27岁。临床检查发现右乳体积明显增大。乳腺活检显示为泌乳管状腺瘤。然而,需要免疫组织化学补体。全细胞角蛋白标记的缺失与CD31、CD34(内皮标记物)的强表达形成对比。估计增殖指数(Ki67)为30%。由此得出结论,表型方面与引起血管肉瘤的血管增生有关。经过多学科评估,患者受益于肿瘤的扩大切除。手术标本的组织病理学检查发现浸润性间充质增生,由不同大小的血管与病变限制的血管缝吻合而成。手术标本的免疫组化检查显示与活检相同的表型。最终诊断为不完全切除的高级别乳腺血管肉瘤。患者拒绝任何额外的手术治疗;患者接受外部放射治疗并密切观察。经过8个月的发展,没有局部或远处复发的报道。结论:原发性乳腺血管肉瘤是一种罕见的血管源性间充质恶性肿瘤。我们的观察是特殊的,因为没有任何先前的放疗,它的临床表现,它的形态表型特征,它的管理和进化方面。
{"title":"Primary breast angiosarcoma: a rare presentation of rare tumor - case report.","authors":"Fayçal Abbad,&nbsp;Najat Cherif Idrissi,&nbsp;Btissam Fatih,&nbsp;Bouchra Fakhir,&nbsp;Jamal Drissi,&nbsp;Mouna Khouchani,&nbsp;Hanane Rais","doi":"10.1186/s12907-017-0055-y","DOIUrl":"https://doi.org/10.1186/s12907-017-0055-y","url":null,"abstract":"<p><strong>Background: </strong>Primary breast angiosarcoma is defined as malignant proliferation showing endothelial differentiation. It is a very rare tumour (0.05% of primary mammary cancers), whose diagnosis can be difficult.</p><p><strong>Case presentation: </strong>We report the observation of a patient with no previous history, aged 27 years. The clinical examination finds a right breast discreetly increased in volume. The trucut biopsy was in favour of a lactating tubular adenoma. However, an immunohistochemical complement was requested. An absence of pancytokeratin labelling contrasted with strong expression of CD31, CD34 (endothelial markers) are described. The proliferation index (Ki67) was estimated at 30%. This led to the conclusion that the phenotypic aspect is related to a vascular proliferation that evokes an angiosarcoma. After a multidisciplinary assessment, the patient benefited from an enlarged excision of the tumour. The histopathological examination of the surgical specimen found an infiltrating mesenchymal proliferation made of vessels of variable sizes anastomosed to vascular slits with lesional limits. The immunohistochemical examination on the surgical specimen showed to the same phenotypic profile on biopsy. The final diagnosis was a high-grade mammary angiosarcoma of incomplete excision. The patient refused any additional surgical management; external radiotherapy and close supervision were prescribed. After eight months of evolution, no local or remote recurrence was reported.</p><p><strong>Conclusion: </strong>Primary breast angiosarcoma is a mesenchymal malignant tumour of rare vascular origin. Our observation is peculiar by the absence of any prior radiotherapy, its clinical presentation, its morpho-phenotypic characteristics, its management and its evolutive aspects.</p>","PeriodicalId":35804,"journal":{"name":"BMC Clinical Pathology","volume":"17 ","pages":"17"},"PeriodicalIF":0.0,"publicationDate":"2017-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12907-017-0055-y","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35312138","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Accuracy of cervical cytology: comparison of diagnoses of 100 Pap smears read by four pathologists at three hospitals in Norway. 宫颈细胞学的准确性:由挪威三家医院的四位病理学家阅读的100份巴氏涂片诊断的比较。
Q2 Medicine Pub Date : 2017-08-29 eCollection Date: 2017-01-01 DOI: 10.1186/s12907-017-0058-8
Sveinung Wergeland Sørbye, Pål Suhrke, Berit Wallem Revå, Jannicke Berland, Ramona Johansen Maurseth, Khalid Al-Shibli

Background: Cervical cancer can be prevented by early detection and treatment for precancerous lesions. Since 1995, there has been a national cervical cancer screening program in Norway, where women aged 25-69 years are recommended to take Pap smears every three years. There are 17 cytology laboratories covering a population of 5 million people. The detection rate of cervical abnormalities varies from laboratory to laboratory. We wanted to investigate the accuracy of cytology diagnoses by four different pathologists at three different hospitals in Norway.

Methods: One hundred Pap smears (20 Normal, 20 ASC-US, 20 LSIL, 20 ASC-H and 20 HSIL) screened at UNN in 2015 were evaluated by four pathologists at three hospitals in Norway. All patients were followed up through December 2016. Histologically confirmed high-grade dysplasia (CIN2+) was considered as study endpoint.

Results: The number of Pap smears evaluated as abnormal (ASC-US+) by the four pathologists varied from 61 to 85. The number of high-grade cytology (ASC-H+) varied from 26 to 50. There was moderate agreement (weighted kappa 0.45-0.58) between the observers. There were 32 women with high-grade histology (CIN2+) in the follow-up, including 19 CIN2, 12 CIN3 and one squamous cell carcinoma (SCC). Using high-grade cytology (ASC-H+) as cut-off, the sensitivity for CIN2+ varied from 68.8% to 93.8% (mean 77.4%) and specificity from 70.6% to 95.6% (mean 81.3%). The pathologist with the highest sensitivity for CIN2+ had the highest false positive rate and the lowest specificity (p<0.05). The accuracy for CIN2+ varied from 74.1% to 83.8% (mean 79.4%). The Pap smear from the woman with cervical cancer was diagnosed as high-grade (ASC-H+) by one of the four pathologists.

Conclusions: Cervical cancer screening based on cytology has limited accuracy. The study revealed a moderate agreement between the observers, along with a trade-off between sensitivity and specificity. This might indicate that hospitals with high detection rates of cervical cytology have higher sensitivity for CIN2+ but lower specificity.

背景:宫颈癌可以通过早期发现和治疗癌前病变来预防。自1995年以来,挪威开展了一项全国宫颈癌筛查计划,建议25-69岁的妇女每三年接受一次巴氏涂片检查。有17个细胞学实验室,覆盖人口500万。宫颈异常的检出率因实验室而异。我们想调查挪威三家不同医院的四位不同病理学家的细胞学诊断的准确性。方法:由挪威3家医院的4名病理学家对2015年在UNN筛查的100例巴氏涂片(20例正常、20例ASC-US、20例LSIL、20例ASC-H和20例HSIL)进行评估。所有患者随访至2016年12月。组织学证实的高度不典型增生(CIN2+)被认为是研究终点。结果:四位病理学家评估为异常(ASC-US+)的巴氏涂片数量从61到85不等。高级别细胞学(ASC-H+)的数目在26 - 50之间。观察者之间有中等程度的一致性(加权kappa 0.45-0.58)。随访中,32例患者组织学分级(CIN2+),其中CIN2 19例,CIN3 12例,鳞状细胞癌(SCC) 1例。以高级别细胞学(ASC-H+)作为截止点,CIN2+的敏感性从68.8%到93.8%(平均77.4%),特异性从70.6%到95.6%(平均81.3%)。CIN2+敏感性最高的病理医师假阳性率最高,特异性最低(p结论:基于细胞学的宫颈癌筛查准确性有限。该研究揭示了观察者之间的适度一致,以及敏感性和特异性之间的权衡。这可能说明宫颈细胞学检出率高的医院对CIN2+的敏感性较高,但特异性较低。
{"title":"Accuracy of cervical cytology: comparison of diagnoses of 100 Pap smears read by four pathologists at three hospitals in Norway.","authors":"Sveinung Wergeland Sørbye,&nbsp;Pål Suhrke,&nbsp;Berit Wallem Revå,&nbsp;Jannicke Berland,&nbsp;Ramona Johansen Maurseth,&nbsp;Khalid Al-Shibli","doi":"10.1186/s12907-017-0058-8","DOIUrl":"https://doi.org/10.1186/s12907-017-0058-8","url":null,"abstract":"<p><strong>Background: </strong>Cervical cancer can be prevented by early detection and treatment for precancerous lesions. Since 1995, there has been a national cervical cancer screening program in Norway, where women aged 25-69 years are recommended to take Pap smears every three years. There are 17 cytology laboratories covering a population of 5 million people. The detection rate of cervical abnormalities varies from laboratory to laboratory. We wanted to investigate the accuracy of cytology diagnoses by four different pathologists at three different hospitals in Norway.</p><p><strong>Methods: </strong>One hundred Pap smears (20 Normal, 20 ASC-US, 20 LSIL, 20 ASC-H and 20 HSIL) screened at UNN in 2015 were evaluated by four pathologists at three hospitals in Norway. All patients were followed up through December 2016. Histologically confirmed high-grade dysplasia (CIN2+) was considered as study endpoint.</p><p><strong>Results: </strong>The number of Pap smears evaluated as abnormal (ASC-US+) by the four pathologists varied from 61 to 85. The number of high-grade cytology (ASC-H+) varied from 26 to 50. There was moderate agreement (weighted kappa 0.45-0.58) between the observers. There were 32 women with high-grade histology (CIN2+) in the follow-up, including 19 CIN2, 12 CIN3 and one squamous cell carcinoma (SCC). Using high-grade cytology (ASC-H+) as cut-off, the sensitivity for CIN2+ varied from 68.8% to 93.8% (mean 77.4%) and specificity from 70.6% to 95.6% (mean 81.3%). The pathologist with the highest sensitivity for CIN2+ had the highest false positive rate and the lowest specificity (<i>p</i><0.05). The accuracy for CIN2+ varied from 74.1% to 83.8% (mean 79.4%). The Pap smear from the woman with cervical cancer was diagnosed as high-grade (ASC-H+) by one of the four pathologists.</p><p><strong>Conclusions: </strong>Cervical cancer screening based on cytology has limited accuracy. The study revealed a moderate agreement between the observers, along with a trade-off between sensitivity and specificity. This might indicate that hospitals with high detection rates of cervical cytology have higher sensitivity for CIN2+ but lower specificity.</p>","PeriodicalId":35804,"journal":{"name":"BMC Clinical Pathology","volume":"17 ","pages":"18"},"PeriodicalIF":0.0,"publicationDate":"2017-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12907-017-0058-8","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35316708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 46
Primary ovarian angiosarcoma in a 12- year -old girl: a case report of an exceptional localization in a context of limited resources country. 1例12岁女童原发性卵巢血管肉瘤:在资源有限的国家中罕见的局部病例报告。
Q2 Medicine Pub Date : 2017-08-24 eCollection Date: 2017-01-01 DOI: 10.1186/s12907-017-0056-x
Tchin Darré, Abdoul-Samadou Aboubakari, Bingo K N'Bortche, Akila Bassowa, Solange Adani-Ifé, Gado Napo-Koura

Background: Ovarian sarcomas represent less than 1% of all ovary cancers and usually are frequent in adults. Primary angiosarcomas are exceptional in the ovaries within children.

Case presentation: We reported a case of primary ovarian angiosarcoma in a 12-year-old girl in a resource-constrained context. Immunohistochemistry study showed the positivity of CD34, CD31, factor VIII, while S100 was negative. The diagnosis of primary non-metastatic angiosarcoma was retained. She was unable to undergo the CWS-2002P chemotherapy since her parents could not afford it.

Conclusion: This case report described a rare type of a primary ovarian angiosarcoma within a child, diagnosed in a low-income country in a laboratory with limited resources.

背景:卵巢肉瘤占所有卵巢癌的不到1%,通常常见于成人。原发性血管肉瘤在儿童卵巢中是罕见的。病例介绍:我们报告了一例原发性卵巢血管肉瘤的12岁女孩在资源有限的情况下。免疫组化结果显示CD34、CD31、因子VIII阳性,S100阴性。保留原发非转移性血管肉瘤的诊断。她无法接受CWS-2002P化疗,因为她的父母负担不起。结论:本病例报告描述了一个罕见类型的原发性卵巢血管肉瘤的儿童,诊断在一个低收入国家的实验室有限的资源。
{"title":"Primary ovarian angiosarcoma in a 12- year -old girl: a case report of an exceptional localization in a context of limited resources country.","authors":"Tchin Darré,&nbsp;Abdoul-Samadou Aboubakari,&nbsp;Bingo K N'Bortche,&nbsp;Akila Bassowa,&nbsp;Solange Adani-Ifé,&nbsp;Gado Napo-Koura","doi":"10.1186/s12907-017-0056-x","DOIUrl":"https://doi.org/10.1186/s12907-017-0056-x","url":null,"abstract":"<p><strong>Background: </strong>Ovarian sarcomas represent less than 1% of all ovary cancers and usually are frequent in adults. Primary angiosarcomas are exceptional in the ovaries within children.</p><p><strong>Case presentation: </strong>We reported a case of primary ovarian angiosarcoma in a 12-year-old girl in a resource-constrained context. Immunohistochemistry study showed the positivity of CD34, CD31, factor VIII, while S100 was negative. The diagnosis of primary non-metastatic angiosarcoma was retained. She was unable to undergo the CWS-2002P chemotherapy since her parents could not afford it.</p><p><strong>Conclusion: </strong>This case report described a rare type of a primary ovarian angiosarcoma within a child, diagnosed in a low-income country in a laboratory with limited resources.</p>","PeriodicalId":35804,"journal":{"name":"BMC Clinical Pathology","volume":"17 ","pages":"16"},"PeriodicalIF":0.0,"publicationDate":"2017-08-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12907-017-0056-x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35356699","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Cerebrospinal fluid pleocytosis level as a diagnostic predictor? A cross-sectional study. 脑脊液多细胞血症水平作为诊断预测指标?横断面研究。
Q2 Medicine Pub Date : 2017-08-24 eCollection Date: 2017-01-01 DOI: 10.1186/s12907-017-0053-0
Anne Ahrens Østergaard, Thomas Vognbjerg Sydenham, Mads Nybo, Åse Bengård Andersen

Background: Lumbar puncture with quantification of leukocytes and differential count of cellular subsets in the cerebrospinal fluid is a standard procedure in cases of suspected neuroinfectious conditions. However, a number of non-infectious causes may result in a low leukocyte number (0-1000 cells/ml). We wanted to assess the diagnostic diversity of unselected adult patients with pleocytosis in the cerebrospinal fluid.

Methods: The study is based on data from cerebrospinal fluid (CSF) analyses of all adult patients (15 years or older) admitted to a large university hospital in Denmark during a two-year period (2008-2009). Data from the local patient administrative system supplied with data from patient charts were combined with laboratory data.

Results: A total of 5390 cerebrospinal fluid samples from 3290 patients were included. Pleocytosis >5 leucocytes/μl was found in samples from 262 patients of which 106 (40.5%) were caused by infection of the central nervous system (CNS), 20 (7.6%) by infection outside CNS, 79 (30.2%) due to non-infectious neurological diseases, 23 (8.8%) by malignancy, and 34 (13.0%) caused by other conditions. Significantly higher mean CSF leukocytes was found in patients suffering from CNS infection (mean 1135 cells/μl, p-value <0.0001).

Conclusions: CNS infection, non-infectious neurological disease, malignancy, and infection outside CNS can cause pleocytosis of the cerebrospinal fluid. Leukocyte counts above 100/μl is mainly caused by CNS infection, whereas the number of differential diagnoses is higher if the CSF leukocyte counts is below 50/μl. These conditions are most commonly caused by non-infectious neurological diseases including seizures.

背景:腰穿刺与定量白细胞和脑脊液细胞亚群的差异计数是一个标准的程序,在病例疑似神经感染性疾病。然而,一些非传染性原因可能导致白细胞数量低(0-1000细胞/ml)。我们想评估未选择的脑脊液多细胞症成年患者的诊断多样性。方法:该研究基于丹麦一家大型大学医院在两年内(2008-2009年)收治的所有成年患者(15岁或以上)的脑脊液(CSF)分析数据。来自当地患者管理系统的数据以及来自患者图表的数据与实验室数据相结合。结果:共纳入3290例患者的5390份脑脊液样本。262例患者外周血白细胞增多>5个/μl,其中中枢神经系统感染所致106例(40.5%),中枢神经系统外感染20例(7.6%),非感染性神经系统疾病79例(30.2%),恶性肿瘤23例(8.8%),其他34例(13.0%)。结论:中枢神经系统感染、非感染性神经系统疾病、恶性肿瘤及中枢神经系统外感染均可引起脑脊液多细胞增多。白细胞计数高于100/μl主要是由中枢神经系统感染引起的,而脑脊液白细胞计数低于50/μl则有较多的鉴别诊断。这些情况最常由包括癫痫发作在内的非传染性神经系统疾病引起。
{"title":"Cerebrospinal fluid pleocytosis level as a diagnostic predictor? A cross-sectional study.","authors":"Anne Ahrens Østergaard,&nbsp;Thomas Vognbjerg Sydenham,&nbsp;Mads Nybo,&nbsp;Åse Bengård Andersen","doi":"10.1186/s12907-017-0053-0","DOIUrl":"https://doi.org/10.1186/s12907-017-0053-0","url":null,"abstract":"<p><strong>Background: </strong>Lumbar puncture with quantification of leukocytes and differential count of cellular subsets in the cerebrospinal fluid is a standard procedure in cases of suspected neuroinfectious conditions. However, a number of non-infectious causes may result in a low leukocyte number (0-1000 cells/ml). We wanted to assess the diagnostic diversity of unselected adult patients with pleocytosis in the cerebrospinal fluid.</p><p><strong>Methods: </strong>The study is based on data from cerebrospinal fluid (CSF) analyses of all adult patients (15 years or older) admitted to a large university hospital in Denmark during a two-year period (2008-2009). Data from the local patient administrative system supplied with data from patient charts were combined with laboratory data.</p><p><strong>Results: </strong>A total of 5390 cerebrospinal fluid samples from 3290 patients were included. Pleocytosis >5 leucocytes/μl was found in samples from 262 patients of which 106 (40.5%) were caused by infection of the central nervous system (CNS), 20 (7.6%) by infection outside CNS, 79 (30.2%) due to non-infectious neurological diseases, 23 (8.8%) by malignancy, and 34 (13.0%) caused by other conditions. Significantly higher mean CSF leukocytes was found in patients suffering from CNS infection (mean 1135 cells/μl, <i>p</i>-value <0.0001).</p><p><strong>Conclusions: </strong>CNS infection, non-infectious neurological disease, malignancy, and infection outside CNS can cause pleocytosis of the cerebrospinal fluid. Leukocyte counts above 100/μl is mainly caused by CNS infection, whereas the number of differential diagnoses is higher if the CSF leukocyte counts is below 50/μl. These conditions are most commonly caused by non-infectious neurological diseases including seizures.</p>","PeriodicalId":35804,"journal":{"name":"BMC Clinical Pathology","volume":"17 ","pages":"15"},"PeriodicalIF":0.0,"publicationDate":"2017-08-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12907-017-0053-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35312137","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 17
The use of dielectric blood coagulometry in the evaluation of coagulability in patients with peripheral arterial disease. 介电凝血法评价外周动脉疾病患者的凝血能力。
Q2 Medicine Pub Date : 2017-08-23 eCollection Date: 2017-01-01 DOI: 10.1186/s12907-017-0054-z
Kimihiro Igari, Toshifumi Kudo, Takahiro Toyofuku, Yoshinori Inoue

Background: Platelets and coagulation proteins contribute to the development of peripheral arterial disease, especially atherosclerotic disease. Several experimental studies have proven a significant correlation between hypercoagulability and atherosclerosis. We used dielectric blood coagulometry, which was initially designed to evaluate the coagulable status, to examine the coagulability of peripheral arterial disease patients, and investigated the factors that were significantly correlated with the results.

Methods: We performed dielectric blood coagulometry in 49 peripheral arterial disease patients. In addition, we recorded the patients' demographic information, including the presence of comorbidities, hemodynamic status, and laboratory findings. To investigate coagulability, we calculated the Tmax value, which indicates the time from recalcification to maximum normalized permittivity.

Results: The Tmax values of diabetes mellitus patients were significantly lower than those of non-diabetic patients (1 MHz, P = 0.010; 10 MHz, 0.011). Furthermore, the Tmax value was statistically correlated with the activated partial thromboplastin time (1 MHz, ρ = 0.286, P = 0.048; 10 MHz, ρ = 0.301, P = 0.037).

Conclusions: Dielectric blood coagulometry detected the hypercoagulable status in diabetes mellitus patients, and reflected their level of coagulability, which was also evaluated by the activated partial thromboplastin time.

背景:血小板和凝血蛋白参与外周动脉疾病的发展,尤其是动脉粥样硬化性疾病。一些实验研究已经证明了高凝性与动脉粥样硬化之间的显著相关性。我们使用最初设计用于评估可凝状态的介电血凝测定法检测外周动脉疾病患者的可凝性,并探讨与结果显著相关的因素。方法:对49例外周动脉疾病患者进行介电凝血测定。此外,我们记录了患者的人口统计信息,包括合并症的存在、血液动力学状态和实验室结果。为了研究混凝性,我们计算了Tmax值,它表示从再钙化到最大归一化介电常数的时间。结果:糖尿病患者Tmax值显著低于非糖尿病患者(1 MHz, P = 0.010;10mhz, 0.011)。Tmax值与活化的部分凝血活酶时间(1 MHz, ρ = 0.286, P = 0.048;10 MHz, ρ = 0.301, P = 0.037)。结论:介质凝血法检测糖尿病患者的高凝状态,反映其凝血能力水平,并通过活化的部分凝血活素时间评价其凝血能力。
{"title":"The use of dielectric blood coagulometry in the evaluation of coagulability in patients with peripheral arterial disease.","authors":"Kimihiro Igari,&nbsp;Toshifumi Kudo,&nbsp;Takahiro Toyofuku,&nbsp;Yoshinori Inoue","doi":"10.1186/s12907-017-0054-z","DOIUrl":"https://doi.org/10.1186/s12907-017-0054-z","url":null,"abstract":"<p><strong>Background: </strong>Platelets and coagulation proteins contribute to the development of peripheral arterial disease, especially atherosclerotic disease. Several experimental studies have proven a significant correlation between hypercoagulability and atherosclerosis. We used dielectric blood coagulometry, which was initially designed to evaluate the coagulable status, to examine the coagulability of peripheral arterial disease patients, and investigated the factors that were significantly correlated with the results.</p><p><strong>Methods: </strong>We performed dielectric blood coagulometry in 49 peripheral arterial disease patients. In addition, we recorded the patients' demographic information, including the presence of comorbidities, hemodynamic status, and laboratory findings. To investigate coagulability, we calculated the T<sub>max</sub> value, which indicates the time from recalcification to maximum normalized permittivity.</p><p><strong>Results: </strong>The T<sub>max</sub> values of diabetes mellitus patients were significantly lower than those of non-diabetic patients (1 MHz, <i>P</i> = 0.010; 10 MHz, 0.011). Furthermore, the T<sub>max</sub> value was statistically correlated with the activated partial thromboplastin time (1 MHz, ρ = 0.286, <i>P</i> = 0.048; 10 MHz, ρ = 0.301, <i>P</i> = 0.037).</p><p><strong>Conclusions: </strong>Dielectric blood coagulometry detected the hypercoagulable status in diabetes mellitus patients, and reflected their level of coagulability, which was also evaluated by the activated partial thromboplastin time.</p>","PeriodicalId":35804,"journal":{"name":"BMC Clinical Pathology","volume":"17 ","pages":"14"},"PeriodicalIF":0.0,"publicationDate":"2017-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12907-017-0054-z","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35356698","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Malignant Deciduoid Mesothelioma: case presentation of an exceptional variant and review of the literature. 恶性蜕膜样间皮瘤:一个特殊变异的病例介绍和文献回顾。
Q2 Medicine Pub Date : 2017-08-18 eCollection Date: 2017-01-01 DOI: 10.1186/s12907-017-0051-2
Mouna Khmou, Soumiya Echcharif, Rachad Kabbaj, Basma El Khannoussi

Background: Malignant Deciduoid Mesothelioma (MDM) is an extremely rare variant of epithelioid mesothelioma. It was first described in young females, in the peritoneum, and its relation with asbestos was not well defined. Later reports, have shown that this variant may also occur in the pleura, the pericardium and the tunica vaginalis of elderly people, who had been exposed to asbestos.

Case presentation: We report a case of malignant deciduoid mesothelioma that occurred in the peritoneal cavity, and the omentum of a 35-year-old woman. The patient had never been exposed to asbestos.

Conclusions: Through this observation, we describe clinical, histopathological, and immunohistochemical findings of deciduoid mesothelioma, and review the literature reports.

背景:恶性蜕膜样间皮瘤(MDM)是一种极为罕见的上皮样间皮瘤。它首先在年轻女性腹膜中被描述,它与石棉的关系没有很好的定义。后来的报道表明,这种变异也可能发生在接触过石棉的老年人的胸膜、心包和阴道膜。病例介绍:我们报告一例恶性蜕膜样间皮瘤发生在腹膜腔,网膜的一个35岁的妇女。病人从未接触过石棉。结论:通过观察,我们描述了蜕膜样间皮瘤的临床、组织病理学和免疫组织化学表现,并回顾了文献报道。
{"title":"Malignant Deciduoid Mesothelioma: case presentation of an exceptional variant and review of the literature.","authors":"Mouna Khmou, Soumiya Echcharif, Rachad Kabbaj, Basma El Khannoussi","doi":"10.1186/s12907-017-0051-2","DOIUrl":"10.1186/s12907-017-0051-2","url":null,"abstract":"<p><strong>Background: </strong>Malignant Deciduoid Mesothelioma (MDM) is an extremely rare variant of epithelioid mesothelioma. It was first described in young females, in the peritoneum, and its relation with asbestos was not well defined. Later reports, have shown that this variant may also occur in the pleura, the pericardium and the tunica vaginalis of elderly people, who had been exposed to asbestos.</p><p><strong>Case presentation: </strong>We report a case of malignant deciduoid mesothelioma that occurred in the peritoneal cavity, and the omentum of a 35-year-old woman. The patient had never been exposed to asbestos.</p><p><strong>Conclusions: </strong>Through this observation, we describe clinical, histopathological, and immunohistochemical findings of deciduoid mesothelioma, and review the literature reports.</p>","PeriodicalId":35804,"journal":{"name":"BMC Clinical Pathology","volume":"17 ","pages":"13"},"PeriodicalIF":0.0,"publicationDate":"2017-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12907-017-0051-2","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35429743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Differential expression of CK20, β-catenin, and MUC2/5AC/6 in Lynch syndrome and familial colorectal cancer type X. CK20、β-catenin、MUC2/5AC/6在Lynch综合征和家族性结直肠癌X型中的差异表达
Q2 Medicine Pub Date : 2017-08-17 eCollection Date: 2017-01-01 DOI: 10.1186/s12907-017-0052-1
Stefan Haraldsson, Louise Klarskov, Mef Nilbert, Inge Bernstein, Jesper Bonde, Susanne Holck

Background: Hereditary non-polyposis colorectal cancer comprises Lynch syndrome and familial colorectal cancer type X (FCCTX). Differences in genetics, demographics and histopathology have been extensively studied. The purpose of this study is to characterize their immunoprofile of markers other than MMR proteins.

Methods: We compared the expression patterns of cytokeratins (CK7 and CK20), mucins (MUC2/5 AC/6), CDX2 and β-catenin in Lynch syndrome and FCCTX.

Results: Differences were identified for CK20 and nuclear β-catenin, which were significantly more often expressed in FCCTX than in Lynch syndrome (p < 0.001), whereas MUC2, MUC5AC and MUC6 were overexpressed in Lynch syndrome tumors compared with FCCTX tumors (p = 0.001, < 0.01, and < 0.001, respectively). We observed no differences in the expression patterns of CK7 and CDX2.

Conclusions: In summary, we identified significant differences in the immunoprofiles of colorectal cancers linked to FCCTX and Lynch syndrome with a more sporadic-like profile in the former group and a more distinct profile with frequent MUC6 positivity in the latter group.

背景:遗传性非息肉病性结直肠癌包括Lynch综合征和家族性结直肠癌X型(FCCTX)。遗传学、人口统计学和组织病理学方面的差异已被广泛研究。本研究的目的是表征除MMR蛋白外的其他标志物的免疫谱。方法:比较细胞角蛋白(CK7和CK20)、粘蛋白(MUC2/5 AC/6)、CDX2和β-catenin在Lynch综合征和FCCTX中的表达规律。结果:CK20和细胞核β-catenin在FCCTX中的表达明显高于Lynch综合征(p p = 0.001)。结论:综上所述,我们发现与FCCTX和Lynch综合征相关的结直肠癌的免疫谱存在显著差异,前者具有更散发性的特征,后者具有更明显的MUC6阳性特征。
{"title":"Differential expression of CK20, β-catenin, and MUC2/5AC/6 in Lynch syndrome and familial colorectal cancer type X.","authors":"Stefan Haraldsson,&nbsp;Louise Klarskov,&nbsp;Mef Nilbert,&nbsp;Inge Bernstein,&nbsp;Jesper Bonde,&nbsp;Susanne Holck","doi":"10.1186/s12907-017-0052-1","DOIUrl":"https://doi.org/10.1186/s12907-017-0052-1","url":null,"abstract":"<p><strong>Background: </strong>Hereditary non-polyposis colorectal cancer comprises Lynch syndrome and familial colorectal cancer type X (FCCTX). Differences in genetics, demographics and histopathology have been extensively studied. The purpose of this study is to characterize their immunoprofile of markers other than MMR proteins.</p><p><strong>Methods: </strong>We compared the expression patterns of cytokeratins (CK7 and CK20), mucins (MUC2/5 AC/6), CDX2 and β-catenin in Lynch syndrome and FCCTX.</p><p><strong>Results: </strong>Differences were identified for CK20 and nuclear β-catenin, which were significantly more often expressed in FCCTX than in Lynch syndrome (<i>p</i> < 0.001), whereas MUC2, MUC5AC and MUC6 were overexpressed in Lynch syndrome tumors compared with FCCTX tumors (<i>p</i> = 0.001, < 0.01, and < 0.001, respectively). We observed no differences in the expression patterns of CK7 and CDX2.</p><p><strong>Conclusions: </strong>In summary, we identified significant differences in the immunoprofiles of colorectal cancers linked to FCCTX and Lynch syndrome with a more sporadic-like profile in the former group and a more distinct profile with frequent MUC6 positivity in the latter group.</p>","PeriodicalId":35804,"journal":{"name":"BMC Clinical Pathology","volume":"17 ","pages":"11"},"PeriodicalIF":0.0,"publicationDate":"2017-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12907-017-0052-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35333653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Inflammatory myofibroblastic tumor of the lacrimal gland: case report of an exceptional location. 泪腺炎性肌纤维母细胞瘤:一个特殊部位的病例报告。
Q2 Medicine Pub Date : 2017-08-17 eCollection Date: 2017-01-01 DOI: 10.1186/s12907-017-0050-3
Adil Boudhas, Mohamed Allaoui, Fouad El Asri, Issam Rharrassi, Mohamed Reda El Ochi, Mohamed Tbouda, Hafsa Chahdi, Abderrahmane Al Bouzidi, Mohamed Oukabli

Background: Inflammatory myofibroblastic tumour (IMT) is a mesenchymal neoplasm of intermediate biological potential that may affect a wide range of anatomic sites but has a particular predilection for the lung and intra-abdominal soft tissues.

Case presentation: We report here an exceptional case of inflammatory myofibroblastic tumor arising in the lacrimal gland and presenting as an orbital mass in a 24-year-old male.

Conclusion: This report aims to discuss the importance of histopathological and immunohistochemical findings in arriving at the diagnosis, which helps dictate the management, treatment and prognosis of the patient.

背景:炎症性肌纤维母细胞瘤(IMT)是一种具有中等生物学潜能的间充质肿瘤,可影响广泛的解剖部位,但特别倾向于肺和腹腔内软组织。病例介绍:我们在此报告一例例外的炎症性肌纤维母细胞肿瘤,起源于泪腺,表现为眼眶肿块,患者为24岁男性。结论:本报告旨在讨论组织病理学和免疫组织化学检查在诊断中的重要性,这有助于指导患者的管理,治疗和预后。
{"title":"Inflammatory myofibroblastic tumor of the lacrimal gland: case report of an exceptional location.","authors":"Adil Boudhas,&nbsp;Mohamed Allaoui,&nbsp;Fouad El Asri,&nbsp;Issam Rharrassi,&nbsp;Mohamed Reda El Ochi,&nbsp;Mohamed Tbouda,&nbsp;Hafsa Chahdi,&nbsp;Abderrahmane Al Bouzidi,&nbsp;Mohamed Oukabli","doi":"10.1186/s12907-017-0050-3","DOIUrl":"https://doi.org/10.1186/s12907-017-0050-3","url":null,"abstract":"<p><strong>Background: </strong>Inflammatory myofibroblastic tumour (IMT) is a mesenchymal neoplasm of intermediate biological potential that may affect a wide range of anatomic sites but has a particular predilection for the lung and intra-abdominal soft tissues.</p><p><strong>Case presentation: </strong>We report here an exceptional case of inflammatory myofibroblastic tumor arising in the lacrimal gland and presenting as an orbital mass in a 24-year-old male.</p><p><strong>Conclusion: </strong>This report aims to discuss the importance of histopathological and immunohistochemical findings in arriving at the diagnosis, which helps dictate the management, treatment and prognosis of the patient.</p>","PeriodicalId":35804,"journal":{"name":"BMC Clinical Pathology","volume":"17 ","pages":"12"},"PeriodicalIF":0.0,"publicationDate":"2017-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12907-017-0050-3","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35333654","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Traceability and distribution of Neisseria meningitidis DNA in archived post mortem tissue samples from patients with systemic meningococcal disease. 系统性脑膜炎球菌病患者死后组织样本中脑膜炎奈瑟菌DNA的可追溯性和分布
Q2 Medicine Pub Date : 2017-08-16 eCollection Date: 2017-01-01 DOI: 10.1186/s12907-017-0049-9
Berit Sletbakk Brusletto, Bernt Christian Hellerud, Else Marit Løberg, Ingeborg Løstegaard Goverud, Åshild Vege, Jens Petter Berg, Petter Brandtzaeg, Reidun Øvstebø

Background: The pathophysiology and outcome of meningococcal septic shock is closely associated with the plasma level of N. meningitidis lipopolysaccharides (LPS, endotoxin) and the circulating level of meningococcal DNA. The aim of the present study was to quantify the number of N. meningitidis in different formalin-fixed, paraffin-embedded (FFPE) tissue samples and fresh frozen (FF) tissue samples from patients with systemic meningococcal disease (SMD), to explore the distribution of N. meningitidis in the body.

Methods: DNA in FFPE and FF tissue samples from heart, lungs, liver, kidneys, spleen and brain from patients with meningococcal shock and controls (lethal pneumococcal infection) stored at variable times, were isolated. The bacterial load of N. meningitidis DNA was analyzed using quantitative real-time PCR (qPCR) and primers for the capsule transport A (ctrA) gene (1 copy per N. meningitidis DNA). The human beta-hemoglobin (HBB) gene was quantified to evaluate effect of the storage times (2-28 years) and storage method in archived tissue.

Results: N. meningitidis DNA was detected in FFPE and FF tissue samples from heart, lung, liver, kidney, and spleen in all patients with severe shock. In FFPE brain, N. meningitidis DNA was only detected in the patient with the highest concentration of LPS in the blood at admission to hospital. The highest levels of N. meningitidis DNA were found in heart tissue (median value 3.6 × 107 copies N. meningitidis DNA/μg human DNA) and lung tissue (median value 3.1 × 107 copies N. meningitidis DNA/μg human DNA) in all five patients. N. meningitidis DNA was not detectable in any of the tissue samples from two patients with clinical meningitis and the controls (pneumococcal infection). The quantity of HBB declined over time in FFPE tissue stored at room temperature, suggesting degradation of DNA.

Conclusions: High levels of N. meningitidis DNA were detected in the different tissue samples from meningococcal shock patients, particularly in the heart and lungs suggesting seeding and major proliferation of meningococci in these organs during the development of shock, probably contributing to the multiple organ failure. The age of archived tissue samples appear to have an impact on the amount of quantifiable N. meningitidis DNA.

背景:脑膜炎球菌感染性休克的病理生理和转归与血浆中脑膜炎奈瑟菌脂多糖(LPS、内毒素)水平和循环中脑膜炎球菌DNA水平密切相关。本研究旨在定量分析系统性脑膜炎球菌病(SMD)患者不同福尔马林固定、石蜡包埋(FFPE)组织样本和新鲜冷冻(FF)组织样本中脑膜炎奈瑟菌的数量,探讨脑膜炎奈瑟菌在体内的分布。方法:分离不同保存时间的脑膜炎球菌休克患者和对照组(致死性肺炎球菌感染)的心、肺、肝、肾、脾和脑FFPE和FF组织样本中的DNA。采用实时荧光定量PCR (qPCR)和ctrA基因引物(每个脑膜炎奈索菌DNA 1拷贝)分析脑膜炎奈索菌DNA的细菌负荷。对人β -血红蛋白(HBB)基因进行定量分析,评价保存时间(2 ~ 28年)和保存方法对存档组织的影响。结果:所有重症休克患者的心、肺、肝、肾、脾FFPE和FF组织样本中均检测到脑膜炎奈瑟菌DNA。在FFPE脑中,仅在入院时血液中LPS浓度最高的患者中检测到脑膜炎奈瑟菌DNA。5例患者的心脏组织(中位数为3.6 × 107拷贝/μg人DNA)和肺组织(中位数为3.1 × 107拷贝/μg人DNA)的脑膜炎奈菌DNA含量最高。在两名临床脑膜炎患者和对照组(肺炎球菌感染)的任何组织样本中均未检测到脑膜炎奈瑟菌DNA。在室温下储存的FFPE组织中,HBB的数量随着时间的推移而下降,表明DNA的降解。结论:在脑膜炎球菌性休克患者的不同组织样本中检测到高水平的脑膜炎奈瑟菌DNA,特别是在心脏和肺部,提示在休克发展过程中,脑膜炎球菌在这些器官中播种和大量增殖,可能导致多器官衰竭。存档组织样本的年龄似乎对可量化的脑膜炎奈瑟菌DNA的数量有影响。
{"title":"Traceability and distribution of <i>Neisseria meningitidis</i> DNA in archived post mortem tissue samples from patients with systemic meningococcal disease.","authors":"Berit Sletbakk Brusletto, Bernt Christian Hellerud, Else Marit Løberg, Ingeborg Løstegaard Goverud, Åshild Vege, Jens Petter Berg, Petter Brandtzaeg, Reidun Øvstebø","doi":"10.1186/s12907-017-0049-9","DOIUrl":"10.1186/s12907-017-0049-9","url":null,"abstract":"<p><strong>Background: </strong>The pathophysiology and outcome of meningococcal septic shock is closely associated with the plasma level of <i>N. meningitidis</i> lipopolysaccharides (LPS, endotoxin) and the circulating level of meningococcal DNA. The aim of the present study was to quantify the number of <i>N. meningitidis</i> in different formalin-fixed, paraffin-embedded (FFPE) tissue samples and fresh frozen (FF) tissue samples from patients with systemic meningococcal disease (SMD), to explore the distribution of <i>N. meningitidis</i> in the body.</p><p><strong>Methods: </strong>DNA in FFPE and FF tissue samples from heart, lungs, liver, kidneys, spleen and brain from patients with meningococcal shock and controls (lethal pneumococcal infection) stored at variable times, were isolated. The bacterial load of <i>N. meningitidis</i> DNA was analyzed using quantitative real-time PCR (qPCR) and primers for the capsule transport A (ctrA) gene (1 copy per <i>N. meningitidis</i> DNA). The human beta-hemoglobin (HBB) gene was quantified to evaluate effect of the storage times (2-28 years) and storage method in archived tissue.</p><p><strong>Results: </strong><i>N. meningitidis</i> DNA was detected in FFPE and FF tissue samples from heart, lung, liver, kidney, and spleen in all patients with severe shock. In FFPE brain, <i>N. meningitidis</i> DNA was only detected in the patient with the highest concentration of LPS in the blood at admission to hospital. The highest levels of <i>N. meningitidis</i> DNA were found in heart tissue (median value 3.6 × 10<sup>7</sup> copies <i>N. meningitidis</i> DNA/μg human DNA) and lung tissue (median value 3.1 × 10<sup>7</sup> copies <i>N. meningitidis</i> DNA/μg human DNA) in all five patients. <i>N. meningitidis</i> DNA was not detectable in any of the tissue samples from two patients with clinical meningitis and the controls (pneumococcal infection). The quantity of HBB declined over time in FFPE tissue stored at room temperature, suggesting degradation of DNA.</p><p><strong>Conclusions: </strong>High levels of <i>N. meningitidis</i> DNA were detected in the different tissue samples from meningococcal shock patients, particularly in the heart and lungs suggesting seeding and major proliferation of meningococci in these organs during the development of shock, probably contributing to the multiple organ failure. The age of archived tissue samples appear to have an impact on the amount of quantifiable <i>N. meningitidis</i> DNA.</p>","PeriodicalId":35804,"journal":{"name":"BMC Clinical Pathology","volume":"17 ","pages":"10"},"PeriodicalIF":0.0,"publicationDate":"2017-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12907-017-0049-9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35333652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
A rare case of poorly differentiated thyroid carcinoma probably arising from a nodular goiter. 一例罕见的低分化甲状腺癌,可能由结节性甲状腺肿引起。
Q2 Medicine Pub Date : 2017-06-02 eCollection Date: 2017-01-01 DOI: 10.1186/s12907-017-0048-x
Hironao Yasuoka, Yasushi Nakamura, Mitsuyoshi Hirokawa, Ken-Ichi Yoshida, Kana Anno, Masayuki Tori, Masahiko Tsujimoto

Background: Some poorly differentiated thyroid carcinomas (PDTC) arise from pre-existing, well-differentiated carcinomas of follicular cell origin; however, others most likely arise de novo. The case of a PDTC adjacent to a pre-existing nodular goiter is very rare.

Case presentation: A patient had a PDTC, a widely invasive, cellular tumor with cells that lacked the nuclear features of a papillary thyroid carcinoma. Carcinoma cells were arranged in trabecular, solid, and microfollicular histological patterns and displayed high mitotic activity. A nodule partially encapsulated in a thick fibrous capsule was found adjacent to the PDTC. The nodule was composed of small or dilated follicles, without papillary carcinoma-like nuclear features, that were consistent with a nodular goiter. The PDTC showed a high Ki-67 labeling index and an NRAS gene mutation (codon 61, Q61K).

Conclusion: These results support our diagnosis of a PDTC, probably arising from a nodular goiter.

背景:一些低分化甲状腺癌(PDTC)起源于先前存在的滤泡细胞来源的高分化癌;然而,其他的很可能是从头开始的。PDTC与已存在的结节性甲状腺肿相邻是非常罕见的。病例介绍:1例患者患甲状腺乳头状癌(PDTC),这是一种广泛浸润的细胞肿瘤,其细胞缺乏甲状腺乳头状癌的核特征。癌细胞呈小梁状、实体状和微滤泡状排列,有丝分裂活性高。在PDTC附近发现部分包被厚纤维囊的结节。结节由小的或扩张的卵泡组成,无乳头状癌样核征,符合结节性甲状腺肿。PDTC具有较高的Ki-67标记指数和NRAS基因突变(密码子61,Q61K)。结论:这些结果支持我们的诊断PDTC,可能由结节性甲状腺肿引起。
{"title":"A rare case of poorly differentiated thyroid carcinoma probably arising from a nodular goiter.","authors":"Hironao Yasuoka,&nbsp;Yasushi Nakamura,&nbsp;Mitsuyoshi Hirokawa,&nbsp;Ken-Ichi Yoshida,&nbsp;Kana Anno,&nbsp;Masayuki Tori,&nbsp;Masahiko Tsujimoto","doi":"10.1186/s12907-017-0048-x","DOIUrl":"https://doi.org/10.1186/s12907-017-0048-x","url":null,"abstract":"<p><strong>Background: </strong>Some poorly differentiated thyroid carcinomas (PDTC) arise from pre-existing, well-differentiated carcinomas of follicular cell origin; however, others most likely arise de novo<i>.</i> The case of a PDTC adjacent to a pre-existing nodular goiter is very rare.</p><p><strong>Case presentation: </strong>A patient had a PDTC, a widely invasive, cellular tumor with cells that lacked the nuclear features of a papillary thyroid carcinoma. Carcinoma cells were arranged in trabecular, solid, and microfollicular histological patterns and displayed high mitotic activity. A nodule partially encapsulated in a thick fibrous capsule was found adjacent to the PDTC. The nodule was composed of small or dilated follicles, without papillary carcinoma-like nuclear features, that were consistent with a nodular goiter. The PDTC showed a high Ki-67 labeling index and an <i>NRAS</i> gene mutation (codon 61, Q61K).</p><p><strong>Conclusion: </strong>These results support our diagnosis of a PDTC, probably arising from a nodular goiter.</p>","PeriodicalId":35804,"journal":{"name":"BMC Clinical Pathology","volume":"17 ","pages":"9"},"PeriodicalIF":0.0,"publicationDate":"2017-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12907-017-0048-x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35065720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
期刊
BMC Clinical Pathology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1